Results 111 to 120 of about 16,602 (194)

Transarterial Chemoembolization Combined With Camrelizumab and Rivoceranib for Unresectable Hepatocellular Carcinoma (CHANCE2005/CARES-005): A Randomized Phase II Trial. [PDF]

open access: yesJ Clin Oncol
Zhu HD   +30 more
europepmc   +1 more source

Radioembolization (90Y) achieves higher response rates and reduces progression risk compared with DEB-TACE in hepatocellular carcinoma. [PDF]

open access: yesHepatol Commun
Núñez K   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy